Dana Byrne
- Co-authors
- J. E. ThorpeE T HouangP. V. MacraeYu‐Xiao YangDena M. CarbonariSean HennessyCraig NewcombVincent Lo Re
- Topics
- Antibiotics Pharmacokinetics and Efficacy (4 papers)Hepatitis B Virus Studies (4 papers)Hepatitis C virus research (4 papers)
- Partner nations
- United StatesUkraineUnited Kingdom
In The Last Decade
Dana Byrne
13 papers receiving 168 citations
Peers
Comparison fields: 5 of 54
- Epidemiology 97
- Infectious Diseases 78
- Microbiology 37
- Hepatology 27
- Surgery 26
Countries citing papers authored by Dana Byrne
This map shows the geographic impact of Dana Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Byrne more than expected).
Fields of papers citing papers by Dana Byrne
This network shows the impact of papers produced by Dana Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Byrne. The network helps show where Dana Byrne may publish in the future.
Co-authorship network of co-authors of Dana Byrne
This figure shows the co-authorship network connecting the top 25 collaborators of Dana Byrne. A scholar is included among the top collaborators of Dana Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Byrne. Dana Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 11 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 10 | |
| 10 | 14 | |
| 11 | 0 | |
| 12 | 0 | |
| 13 | 25 | |
| 14 | 17 | |
| 15 | 1 | |
| 16 | 61 |
About Dana Byrne
Dana Byrne is a scholar working on Applied Microbiology and Biotechnology, Hepatology and Infectious Diseases, having authored 16 papers that have together received 171 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Hepatitis B Virus Studies (4 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Microbiology (37 citations), Infectious Diseases (78 citations) and Hepatology (27 citations). Dana Byrne has collaborated with scholars based in United States, Ukraine and United Kingdom. Frequent co-authors include J. E. Thorpe, E T Houang, P. V. Macrae, Yu‐Xiao Yang, Dena M. Carbonari, Sean Hennessy, Craig Newcomb, Vincent Lo Re, Jay R. Kostman and Maximilian Herlim. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.